BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

XOLAIR Pages on BioPortfolio:

Biotechnology News XOLAIR Search
UPDATE 3-U.S. panel rejects Xolair asthma drug for children ... UPDATE: FDA Panel Votes Against Approving Xolair In Children ...
http://www.bioportfolio.co.uk/XOLAIR-news.htm...

BioPortfolio - Xolair
Xolair - BioPortfolio - Indepth. ... Companies working in the area of Xolair from Bioportfolio's Biocorporate database : BioPortfolio Logo. Company Name ...
http://www.bioportfolio.com/indepth/Xolair.html...

Biotechnology News asthma Search
Food and Drug Administration said studies with the asthma drug Xolair, marketed by Novartis AG ... Pediatric studies of Xolair have not revealed any new. ...
http://www.bioportfolio.co.uk/asthma-news.htm...

LeadDiscovery - PharmaNewsBytes European Respiratory Society
A 419-patient study showed that Xolair reduced the rate of clinically significant ... Xolair, the first biotechnology treatment for asthma, was
developed by ...
http://www.bioportfolio.com/LeadDiscovery/pharma_newsbytes_E...

Biotechnology News Asthma Search
UPDATE: FDA: Xolair Asthma Drug Has 'Modest' Benefits In Children ... Food and Drug Administration said studies with the asthma drug Xolair, ...
http://www.bioportfolio.co.uk/Asthma-news.htm...

BioPortfolio - Xolair - InDepth
(http://www.bioportfolio.com/indepth/Xolair.html) - Regularly Updated. ***. Resources from the NCBI used in this document, NCBI's standard disclaimer ...
http://www.bioportfolio.com/indepth/Xolair.pdf...

Biotechnology News Search
Xolair Pediatric (Ages 6-11) BLA Extension Must Overcome 'Relatively Modest' Efficacy _ Xolair Pediatric (Ages 6-11) BLA Extension Must Overcome 'Relatively
...
http://www.bioportfolio.co.uk/Biotechnology_News_from_The%20...

BioPortfolio - Tanox
In October of 2005, Xolair was approved for marketing in all 25 European Union states and is ... Biotech Tracker News - Xolair BLA Re-Submitted December 19,
...
http://www.bioportfolio.com/biocorporate/10015-Tanox.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Wong's BioTech Stock Report - focus on the pipeline Fabrazyme ...
Genentech is hoping Xolair will be approved by the middle of 2003 and its ... We re-iterate that peer-reviewed publications report Xolair's ability to treat ...
http://www.bioportfolio.com/news/biotechsage_6.htm...

Results from other life science and pharmaceutical sites:

Genentech: Medicines: Xolair
Xolair is the first humanized therapeutic antibody for the treatment of asthma and the first approved therapy designed to target the antibody IgE, ...
http://www.gene.com/gene/products/information/immunological/...

Omalizumab - Wikipedia, the free encyclopedia
Omalizumab, trade-named Xolair, received approval by the U.S. Food and Drug ... Treatment with Xolair also reduces the number of FcεRI receptors on ...
http://en.wikipedia.org/wiki/Omalizumab...

XOLAIR Omalizumab For Subcutaneous Use WARNING Anaphylaxis ...
Xolair. Anaphylaxis has occurred as early as after the first dose of Xolair, ... Xolair (Omalizumab) is a recombinant DNA-derived humanized IgG1κ monoclonal ...
http://www.pharma.us.novartis.com/product/pi/pdf/Xolair.pdf...

Genentech: Pipeline: Xolair
Skip to Content for Xolair Menu for Xolair About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu ...
http://www.gene.com/gene/pipeline/status/immunology/xolair/...

Early Communication about an Ongoing Safety Review of Omalizumab ...
16 Jul 2009 ... Xolair is approved for use by adults and adolescents (12 years of age and ... The interim data, submitted by the manufacturer of Xolair ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...

Genentech: Medicines: Xolair Fact Sheet
20 Jun 2003 ... Full prescribing information for Xolair® (Omalizumab)
http://www.gene.com/gene/products/information/immunological/...

Xolair Medication Guide
right after receiving a Xolair injection or hours later. • after any Xolair injection. Anaphylaxis has occurred after the first Xolair injection or after
...
http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089829.pdf...

Genentech: Investors: Xolair - Historical Sales
Skip to Content for Xolair - Historical Sales Menu for Xolair - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors Menu ...
http://www.gene.com/gene/ir/financials/historical/xolair.htm...

Xolair® (Omalizumab) Injectable Medication Precertification ...
For each 150 mg Xolair vial shipped, 1 Xolair kit will be included containing 1- 10cc vial preservative-free sterile water for injection; USP; 3cc syringes; ...
http://www.aetna.com/provider/data/68457_Xolair_Med_Request_...

Omalizumab (marketed as Xolair) - Early Communication about an ...
16 Jul 2009 ... FDA is evaluating interim safety findings from an ongoing study of Xolair ( omalizumab) that suggests an increased number of cardiovascular ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.